RSS feed Get our RSS feed

News by Topic

BizReport : White Papers : Healthcare

How to Use Risk-Based Monitoring and Clinical CAPA to Ensure Compliance

This white paper will discuss the importance of risk-based monitoring and CAPA in clinical research within the context of the following initiatives by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA):

  • 2013 Guidance
  • Clinical Trial Transformation Initiative (CTTI)
  • EMA's Reflection Paper on Risk-Based Quality Management in Clinical Trials

Click here to request your free White Paper!




Copyright © 1999- BizReport. All rights reserved.
Republication or redistribution of BizReport content is expressly prohibited without the prior written consent.
BizReport shall not be liable for any errors in the content, or for any actions taken in reliance thereon.